| PAPTX | QDSNX | PAPTX / QDSNX | |
| Total Expense Ratio | 2.18 | 3.48 | 63% |
| Annual Report Gross Expense Ratio | 2.89 | 3.48 | 83% |
| Fund Existence | 4 years | 6 years | - |
| Gain YTD | 1.931 | 8.954 | 22% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 256M | 9.81B | 3% |
| Annual Yield % from dividends | 3.98 | 1.84 | 216% |
| Returns for 1 year | -1.18 | 15.09 | -8% |
| Returns for 3 years | 12.32 | 45.94 | 27% |
| Returns for 5 years | N/A | 77.18 | - |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MVV | 87.59 | 1.38 | +1.60% |
| ProShares Ultra MidCap400 | |||
| PLUL | 7.41 | 0.09 | +1.27% |
| Leverage Shares 2X Long PLUG Daily ETF | |||
| DEM | 56.61 | 0.36 | +0.64% |
| WisdomTree Emerging Markets High Div ETF | |||
| XJAN | 39.20 | 0.08 | +0.20% |
| FT Vest US Eq Enh & Mod Buf ETF-Jan | |||
| PJP | 129.59 | -0.46 | -0.35% |
| Invesco Pharmaceuticals ETF | |||